EditorialsSSRIs in IBS: Sensing a dash of disappointment
References (45)
Serotoninergic neuroenteric modulators
Lancet
(2001)- et al.
Irritable bowel syndrome: a little understood organic bowel disease?
Lancet
(2002) - et al.
AGA technical review on irritable bowel syndrome
Gastroenterology
(2002) - et al.
Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention
Gastroenterology
(2000) - et al.
Behavioral and physiological sleep characteristics in women with irritable bowel syndrome
Am J Gastroenterol
(2002) - et al.
Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis
Am J Med
(2000) - et al.
Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans
Clin Gastroenterol Hepatol
(2003) - et al.
The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double-blind, randomized, placebo controlled trial
Clin Gastroenterol Hepatol
(2003) - et al.
The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome
Gastroenterology
(2003) - et al.
A double-blind randomized placebo-controlled crossover trial of citalopram, a selective 5-hydroxytryptamine reuptake inhibitor in irritable bowel syndrome
Gastroenterology
(2001)
Citalopram in patients with fibromyalgia—a randomized, double-blind, placebo-controlled study
Eur J Pain
(2000)
Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review
J Pain Symptom Manage
(2000)
Gender-related differences in slowing colonic transit by a 5-HT antagonist in subjects with diarrhea-predominant irritable bowel syndrome
Am J Gastroentrol
(2001)
Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron
Gastroenterology
(2002)
Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome
Gastroenterology
(2002)
Familial association in adults with functional gastrointestinal disorders
Mayo Clin Proc
(2000)
Evidence of genetic contribution to functional bowel disorder
Am J Gastroenterol
(1998)
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology
Gastroenterology
(2001)
Predictors of health care seeking for irritable bowel syndrome: a population based study
Gut
(1997)
Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia
Aliment Pharmacol Ther
(2003)
Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study
Gut
(1998)
Psychological factors in functional gastrointestinal disorders: characteristics of the disorder or of the illness behavior?
Psychosom Med
(1999)
Cited by (21)
Irritable bowel syndrome: dietary and pharmacological therapeutic options
2009, Gastroenterologie Clinique et BiologiqueIrritable bowel syndrome: current treatment options
2007, Presse MedicalePathophysiology and treatment of functional bowel disorders
2005, EMC - Hepato-GastroenterologieSerotonergic Control of Gastrointestinal Development, Motility, and Inflammation
2023, Comprehensive PhysiologyComparison of fluoxetine and duloxetine hydrochloride therapeutic effects on patients with constipation-predominant irritable bowel syndrome
2022, Gastroenterology and Hepatology from Bed to BenchChronic constipation and abdominal pain: Independent or closely interrelated symptoms?
2020, Journal of Gastroenterology and Hepatology (Australia)
Copyright © 2003 American Gastroenterological Association. Published by Elsevier Ltd. All rights reserved.